Effects of rivaroxaban on coagulation tests in patients with non-valvular atrial fibrillation under real-life conditions

Thromb Res. 2017 Jun:154:26-27. doi: 10.1016/j.thromres.2017.03.007. Epub 2017 Mar 9.

Authors

V M Silva¹, M Scanavacca¹, F Darrieux¹, C Cavalheiro-Filho¹, C C Strunz²

Affiliations

¹ Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil.
² Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil. Electronic address: [email protected].

PMID: 28390252
DOI: 10.1016/j.thromres.2017.03.007

No abstract available

Keywords: Activated partial thromboplastin time; Anti-Xa assay; Prothrombin time; Rivaroxaban.

Publication types

Letter

MeSH terms

Aged
Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / pathology
Humans
Rivaroxaban / pharmacology
Rivaroxaban / therapeutic use*

Substances

Anticoagulants
Rivaroxaban